There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.
Justin (JC) Liauw, PharmD, BCOP
Advertisement
Articles by Justin (JC) Liauw, PharmD, BCOP
New potential medications may continue to expand the role of targeted agents.
Advertisement
Latest Updated Articles
Overview of PARP Inhibitors in the Treatment of Ovarian CancerPublished: October 11th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Higher-Dose Semaglutide Achieves Significant Weight Reduction in Adults with Obesity
2
Long COVID May Elevate Risk of Cardiovascular Disease
3
Boehringer Ingelheim Advances Cardio-Kidney-Metabolic Research Through Integrated Therapeutic Development
4
Advanced Wearable Accelerometer Shows Promise in Detecting Functional Capacity and Outcomes in Heart Failure Patients
5
